Antineoplastic Combined Chemotherapy ProtocolsRadiation InjuriesCombined Modality TherapyChemotherapy, AdjuvantRadiotherapyRadiation DosageRadiotherapy DosageRadiation, IonizingDose-Response Relationship, RadiationRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedRadiation ToleranceRadiotherapy, AdjuvantTreatment OutcomeDose FractionationRadiation OncologyRadiotherapy Planning, Computer-AssistedCisplatinAntineoplastic AgentsRadiationBrachytherapyNeoplasm StagingNeoplasm Recurrence, LocalDisease-Free SurvivalRadiation ProtectionRadiation PneumonitisSurvival AnalysisBreast NeoplasmsDoxorubicinRadiosurgerySurvival RateCyclophosphamideCranial IrradiationBrain NeoplasmsRadiation MonitoringPrognosisNeoadjuvant TherapyLung NeoplasmsRadiotherapy, Computer-AssistedRadiometryHead and Neck NeoplasmsRadiation-Sensitizing AgentsNeoplasmsRadiotherapy, Image-GuidedFollow-Up StudiesNeoplasms, Radiation-InducedParticle AcceleratorsEtoposideRadiotherapy, High-EnergyChemoradiotherapyDrug Administration ScheduleAdenocarcinomaCarcinoma, Squamous CellTime FactorsRadiation Injuries, ExperimentalCarboplatinRadiodermatitisOrgans at RiskProstatic NeoplasmsHodgkin DiseaseVinblastineCarcinoma, Non-Small-Cell LungGamma RaysPaclitaxelTomography, X-Ray ComputedDacarbazineMethotrexateActuarial AnalysisBleomycinMastectomy, SegmentalSalvage TherapyRadiation-Protective AgentsRetrospective StudiesNeoplasm MetastasisAntineoplastic Agents, AlkylatingSarcomaCosmic RadiationKaplan-Meier EstimateInduction ChemotherapyAntimetabolites, AntineoplasticTumor BurdenDeoxycytidineLymphatic IrradiationNeoplasms, Second PrimaryRectal NeoplasmsProspective StudiesMastectomyCobalt RadioisotopesClinical Trials as TopicTaxoidsGlioblastomaCerebellar NeoplasmsBone NeoplasmsLomustineNasopharyngeal NeoplasmsIfosfamidePalliative CareLymphatic MetastasisDrug Resistance, NeoplasmCarcinoma